These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 9005996

  • 1. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
    Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, Shimokawa H, Sueishi K, Takeshita A.
    J Clin Invest; 1997 Jan 15; 99(2):278-87. PubMed ID: 9005996
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M, Egashira K, Mitsui T, Chishima S, Takeshita A, Narita H.
    J Mol Cell Cardiol; 2000 Jan 15; 32(1):73-83. PubMed ID: 10652192
    [Abstract] [Full Text] [Related]

  • 3. Augmentation of pulse wave velocity precedes vascular structural changes of the aorta in rats treated with N(omega)-nitro-L-arginine methyl ester.
    Kameyama H, Takeda K, Kusaba T, Narumiya H, Tanda S, Kuwahara N, Yamada K, Tamagaki K, Okigaki M, Hatta T, Sasaki S.
    Hypertens Res; 2005 May 15; 28(5):439-45. PubMed ID: 16156508
    [Abstract] [Full Text] [Related]

  • 4. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
    Simko F, Luptak I, Matuskova J, Babal P, Pechanova O, Bernatova I, Hulin I.
    Ann N Y Acad Sci; 2002 Jun 15; 967():454-62. PubMed ID: 12079874
    [Abstract] [Full Text] [Related]

  • 5. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.
    Takemoto M, Egashira K, Tomita H, Usui M, Okamoto H, Kitabatake A, Shimokawa H, Sueishi K, Takeshita A.
    Hypertension; 1997 Dec 15; 30(6):1621-7. PubMed ID: 9403592
    [Abstract] [Full Text] [Related]

  • 6. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA, Paffaro VA, Pauli JR, da Silva GH, Saad MJ, Salgado I, da Cruz-Höfling MA, Hyslop S.
    Cell Tissue Res; 2007 Jul 15; 329(1):45-58. PubMed ID: 17436021
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 8. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H, Nakagawa Y, Miki S, Shimizu T, Yoshimura A, Inoue R, Asayama J, Kobara M, Nakata T.
    Hypertens Res; 2005 Aug 15; 28(8):689-700. PubMed ID: 16392774
    [Abstract] [Full Text] [Related]

  • 9. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
    Khattab MM, Mostafa A, Al-Shabanah O.
    Kidney Blood Press Res; 2005 Aug 15; 28(4):243-50. PubMed ID: 16220007
    [Abstract] [Full Text] [Related]

  • 10. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
    Kaikita K, Schoenhard JA, Painter CA, Ripley RT, Brown NJ, Fogo AB, Vaughan DE.
    J Mol Cell Cardiol; 2002 Jun 15; 34(6):617-27. PubMed ID: 12054849
    [Abstract] [Full Text] [Related]

  • 11. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J, Ortiz MC, O'Valle F, Alcaraz A, Navarro EG, Vargas F, Evangelista S, Atucha NM.
    Clin Sci (Lond); 2006 Feb 15; 110(2):227-33. PubMed ID: 16197366
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D, Dechaux E, Dowell FJ, Maclour J, Samuel JL, Lévy BI, Michel JB.
    Br J Pharmacol; 1997 May 15; 121(1):83-90. PubMed ID: 9146891
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H, Minamino T, Tsukamoto O, Kim J, Okada K, Myoishi M, Wakeno M, Takashima S, Mochizuki N, Kitakaze M.
    Hypertens Res; 2006 Apr 15; 29(4):277-84. PubMed ID: 16778335
    [Abstract] [Full Text] [Related]

  • 15. [Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
    Sanada S, Node K, Asanuma H, Ogita H, Takashima S, Minamino T, Asakura M, Hori M, Kitakaze M.
    J Cardiol; 2003 Jan 15; 41(1):43-4. PubMed ID: 12564115
    [Abstract] [Full Text] [Related]

  • 16. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
    Numaguchi K, Egashira K, Takemoto M, Kadokami T, Shimokawa H, Sueishi K, Takeshita A.
    Hypertension; 1995 Dec 15; 26(6 Pt 1):957-62. PubMed ID: 7490155
    [Abstract] [Full Text] [Related]

  • 17. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
    Suda O, Tsutsui M, Morishita T, Tanimoto A, Horiuchi M, Tasaki H, Huang PL, Sasaguri Y, Yanagihara N, Nakashima Y.
    Circulation; 2002 Sep 24; 106(13):1729-35. PubMed ID: 12270870
    [Abstract] [Full Text] [Related]

  • 18. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
    Resende AC, Pimentel AM, de Moura RS.
    Clin Exp Pharmacol Physiol; 2004 Nov 24; 31(11):756-61. PubMed ID: 15566389
    [Abstract] [Full Text] [Related]

  • 19. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
    Inaba S, Iwai M, Furuno M, Kanno H, Senba I, Okayama H, Mogi M, Higaki J, Horiuchi M.
    J Hypertens; 2011 Nov 24; 29(11):2236-45. PubMed ID: 21946695
    [Abstract] [Full Text] [Related]

  • 20. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK, Drew GM.
    Br J Pharmacol; 1997 Dec 24; 122(7):1385-94. PubMed ID: 9421286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.